Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
21) Biocon - Biosimilars Coming of Age FY26: Revenue 16,927 Cr (+13%) | Biosimilars 10,431 Cr (+16%) | Q4 Biosimilar EBITDA Margin 26% Biocons biosimilar franchise has reached a scale and profitability that vindicates years of investment
The duration of the effects of glutathione injections can vary from person to person
Also known as Body Protection Compound-157, this peptide is composed of a mix of amino acids that help bolster health in muscles and other tissues
therefore, ethical approval was not required
2, 3, Supplementary Fig
A focused RNAi screen using these mutants has identified div-1 (a homolog of the human PolA2, the B subunit of the DNA polymerase alpha-primase complex) as a positive regulator of GLP-1/Notch signaling
US$ 22.86
US$ 24.00
US$ 21.84
US$ 27.13
US$ 24.86
US$ 25.77
US$ 22.50
US$ 24.01
US$ 29.08
US$ 29.92
